These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17702867)

  • 1. Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice.
    Rommelfanger KS; Edwards GL; Freeman KG; Liles LC; Miller GW; Weinshenker D
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13804-9. PubMed ID: 17702867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential interactive effects of gliotoxin and MPTP in the substantia nigra and the locus coeruleus in BALB/c mice.
    Chang FW; Wang SD; Lu KT; Lee EH
    Brain Res Bull; 1993; 31(3-4):253-66. PubMed ID: 7683960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the substantia nigra and the locus coeruleus in BALB/c mice.
    Hu SC; Chang FW; Sung YJ; Hsu WM; Lee EH
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1379-87. PubMed ID: 1684822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A; Mura A; Hengerer B; Feldon J; Ferger B
    Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norepinephrine deficiency in Parkinson's disease: the case for noradrenergic enhancement.
    Espay AJ; LeWitt PA; Kaufmann H
    Mov Disord; 2014 Dec; 29(14):1710-9. PubMed ID: 25297066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.
    Bazzu G; Calia G; Puggioni G; Spissu Y; Rocchitta G; Debetto P; Grigoletto J; Zusso M; Migheli R; Serra PA; Desole MS; Miele E
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):482-90. PubMed ID: 20522009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
    Fornai F; Alessandrì MG; Torracca MT; Bassi L; Corsini GU
    J Pharmacol Exp Ther; 1997 Oct; 283(1):100-7. PubMed ID: 9336313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity.
    Thomas B; von Coelln R; Mandir AS; Trinkaus DB; Farah MH; Leong Lim K; Calingasan NY; Flint Beal M; Dawson VL; Dawson TM
    Neurobiol Dis; 2007 May; 26(2):312-22. PubMed ID: 17336077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Greene RE; Meshul CK
    Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
    Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Schumm S; Sebban C; Cohen-Salmon C; Callebert J; Launay JM; Golmard JL; Boussicault L; Petropoulos I; Hild A; Rousselet E; Prigent A; Friguet B; Mariani J; Hirsch EC
    J Neurochem; 2012 Sep; 122(5):1032-46. PubMed ID: 22708926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destruction of norepinephrine terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice reduces locomotor activity induced by L-dopa.
    Nishi K; Kondo T; Narabayashi H
    Neurosci Lett; 1991 Feb; 123(2):244-7. PubMed ID: 2027538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intervention with 7,8-dihydroxyflavone blocks further striatal terminal loss and restores motor deficits in a progressive mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Moore C; Meshul CK
    Neuroscience; 2015 Apr; 290():454-71. PubMed ID: 25655214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies of the neurotoxicity of MPTP in rats of different ages.
    Lee EH; Liu SP; Lu KT; Lin WR
    Chin J Physiol; 1992; 35(4):317-36. PubMed ID: 1364057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral responses of dopamine beta-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action.
    Mitchell HA; Bogenpohl JW; Liles LC; Epstein MP; Bozyczko-Coyne D; Williams M; Weinshenker D
    Pharmacol Biochem Behav; 2008 Dec; 91(2):217-22. PubMed ID: 18703079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
    Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM
    J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain perception in acute model mice of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Park J; Lim CS; Seo H; Park CA; Zhuo M; Kaang BK; Lee K
    Mol Pain; 2015 May; 11():28. PubMed ID: 25981600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nei-like 1 inhibition results in motor dysfunction and promotes inflammation in Parkinson's disease mice model.
    Xue B; Xiao W; Tian H
    Biochem Biophys Res Commun; 2020 Jan; 521(1):245-251. PubMed ID: 31653343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.